Michael Burry's Scion Lightens up on Healthcare Portfolio, in Q1 Moves
AbCellera Announces The Federal Circuit Upholds Validity Of Its '408 Patent On Microfluidic Cell-Culturing Devices, Rejecting Bruker Cellular's Invalidity Challenge And Strengthening AbCellera's Position In Ongoing Patent Litigation.
Express News | Trump: An executive order will be signed, and pharmaceutical prices will immediately decrease by 30% to 80%.
Notable Analyst Calls This Week: Uber, Twilio and EQT Among Top Picks
CIBC Maintains Neutral on Mosaic, Raises Price Target to $33
UBS Maintains Neutral on Bruker, Lowers Price Target to $45